T H Svensson Selected Research

T H Svensson Research Topics

3	Schizophrenia (Dementia Praecox) 01/2022 - 03/2000
3	Tobacco Use Disorder (Nicotine Dependence) 01/2002 - 08/2000
3	Catalepsy 01/2001 - 01/2000
2	Mental Disorders (Mental Disorder) 01/2022 - 08/2000
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2022
1	Parkinsonian Disorders (Parkinsonism) 01/2000

3	Nicotine FDA Link 01/2002 - 08/2000
2	RacloprideIBA 03/2000 - 01/2000
2	Antipsychotic Agents (Antipsychotics)IBA 03/2000 - 01/2000
1	lumateperoneIBA 01/2022
1	Dopamine (Intropin)FDA LinkGeneric 01/2022
1	LithiumIBA 01/2022
1	Serotonin (5 Hydroxytryptamine)IBA 01/2022
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	Haloperidol (Haldol)FDA LinkGeneric 10/2002
1	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 01/2001
1	Citalopram FDA LinkGeneric 01/2001
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2001
1	5-HT1A Serotonin ReceptorIBA 01/2001
1	CyclohexaneIBA 01/2001
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 08/2000
1	Phencyclidine (Angel Dust)IBA 03/2000
1	Prazosin (Minipress)FDA LinkGeneric 01/2000
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2000

1	Therapeutics 01/2022
1	Secondary Prevention 01/2002